Clinical observation of metformin combined with rosiglitazone in the treatment of newly diagnosed type
10.3969/j.issn.1005-1678.2017.07.122
- VernacularTitle:二甲双胍联合罗格列酮治疗初发2型糖尿病患者的临床观察
- Author:
Feng JIN
;
Qi CHEN
- Keywords:
rosiglitazone;
metformin;
type 2 diabetes mellitus;
clinical effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):299-300,303
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the primary treatment of type 2 diabetes, clinical effect of rosiglitazone combined with metformin treatment.Methods In 40 patients with type 2 diabetes mellitus patients implementation of routine treatment for metformin, and 40 patients in the control group based on the use of rosiglitazone intervention treatment, two groups of patients in our hospital from January 2015 to December 2016 were compared between the two groups.Results Treatment efficiency, obvious effective rate of observation group were higher in the observation group was 95%, while only 82.5% of the control group,comparison between groups showed significant differences(P<0.05);the two groups of patients with fasting blood glucose levels, 2 hour postprandial blood glucose level There were no significant difference before treatment, after treatment group observation group significantly improved, comparison between groups showed significant differences(P<0.05).Conclusion Rosiglitazone Combined with metformin in newly diagnosed type 2 diabetes clinical observation, which can help to improve the clinical symptoms of patients, reduce blood glucose, compared with pure medication.To improve the treatment effect, it is worthy of reference.
